.RESEARCH EMPHASIZE.06 August 2024.
A huge randomized measured trial along with cisgender women highlights the problems of fidelity to a regular oral preexposure prevention routine and shows that twice-yearly treatment of lenacapavir can preserve effective HIV protection amounts over 6 months.